Condition: Alcohol Use Disorder (AUD) · Sponsor: University of Sydney
To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.
This description comes directly from the study's public registry record.
Kirsten Morley, PhD · 61295153636 · Kirsten.morley@sydney.edu.au
Paul Haber, MBBS · paul.haber@sydney.edu.au
Always discuss trial participation with your own doctor first.
| Drug Health Services, Royal Prince Alfred Hospital | Sydney, New South Wales, Australia | Recruiting |
| Cornwall Street Medical Centre (UQ Health Care) | Annerley, Queensland, Australia | Not Yet Recruiting |
| Turning Point | Richmond, Victoria, Australia | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05408247